Skip to main content
. 2010 Mar 11;100(1):121–127. doi: 10.1007/s11060-010-0151-7

Fig. 1.

Fig. 1

Progression-free survival of 33 patients on phase II TPDCV chemotherapy trial for pediatric low-grade hypothalamic/chiasmatic gliomas